Huperzine A/Huperzia serrata / Half-Life Cancer Research Results

Hup, Huperzine A/Huperzia serrata: Click to Expand ⟱
Features:
huperzine A is a natural product and has been studied for its potential benefits in Alzheimer's disease (AD).
-inhibits acetylcholinesterase(AChE), the enzyme that breaks down acetylcholine, a key neurotransmitter involved in memory and learning.

Huperzine A (Huperzia serrata) – Alzheimer's Disease (AD) Pathway Matrix

Rank Pathway / Axis AD Direction Mechanism Snapshot TSF Evidence Notes / Clinical Relevance
1 AChE Inhibition ACh ↑ Potent reversible acetylcholinesterase inhibitor → increases synaptic acetylcholine P, R Human trials (moderate) Primary mechanism; similar functional class to donepezil. Improves memory and cognition scores in mild–moderate AD.
2 NMDA Receptor Modulation Excitotoxicity ↓ Partial antagonistic modulation of NMDA receptor signaling R Preclinical + supportive Reduces glutamate-mediated excitotoxicity; complementary to cholinergic effects.
3 Mitochondrial Protection Mito dysfunction ↓ Preserves mitochondrial membrane potential; reduces cytochrome c release R, G Preclinical Supports neuronal survival under oxidative stress conditions.
4 ROS Modulation ROS ↓ (neuronal models) Reduces oxidative stress markers; improves antioxidant enzyme activity R, G Preclinical Neuroprotective antioxidant effect; contrasts with pro-oxidant effect in some cancer cells.
5 Aβ Toxicity Modulation Aβ neurotoxicity ↓ Reduces Aβ-induced neuronal apoptosis G Preclinical Protects against Aβ-mediated mitochondrial and synaptic injury.
6 Tau Pathology p-tau ↓ (model data) Indirect reduction of hyperphosphorylated tau via neuroprotective signaling G Limited preclinical Not a primary anti-tau agent but supportive.
7 BDNF Support BDNF ↑ (indirect) Enhances synaptic plasticity signaling G Preclinical Supports cognitive resilience.
8 Neuroinflammation IL-1β ↓, TNF-α ↓ (model data) Reduces pro-inflammatory cytokines in brain models G Preclinical Anti-inflammatory contribution secondary to cholinergic signaling.

Time-Scale Flag (TSF):
P = 0–30 min (enzyme inhibition)
R = 30 min–3 hr (neurotransmission / mitochondrial signaling shifts)
G = >3 hr (synaptic plasticity, inflammation modulation, neuroprotection)
Half-Life, Half-Life: Click to Expand ⟱
Source:
Type:
For many drugs, the half-life is the time it takes for half of the drug’s active substance to be eliminated from the bloodstream.
In medicine, knowing a drug’s half-life helps in designing treatment regimens that reduce adverse effects.
Scientific Papers found: Click to Expand⟱
3803- Hup,    Huperzine A and Its Neuroprotective Molecular Signaling in Alzheimer’s Disease
- Review, AD, NA
*AChE↓, *neuroP↑, *BBB↑, *Half-Life↑, *cognitive↑, *Dose↝, *BACE↓, *IronCh↑, *TfR1/CD71↓, *ROS↓,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Total Targets: 0

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress ⓘ

ROS↓, 1,  

Metal & Cofactor Biology ⓘ

IronCh↑, 1,   TfR1/CD71↓, 1,  

Barriers & Transport ⓘ

BBB↑, 1,  

Synaptic & Neurotransmission ⓘ

AChE↓, 1,  

Protein Aggregation ⓘ

BACE↓, 1,  

Drug Metabolism & Resistance ⓘ

Dose↝, 1,   Half-Life↑, 1,  

Functional Outcomes ⓘ

cognitive↑, 1,   neuroP↑, 1,  
Total Targets: 10

Scientific Paper Hit Count for: Half-Life, Half-Life
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:343  Target#:1109  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page